Pride Capital sells stake in Kairos to trade

The deal is effective as of 1 March 2021.

Following the acquisition, the management teams of both companies intend to support the companies' national and international growth, according to a statement.

Pride Capital span out from Main Capital in January 2019 and was previously known as Main Mezzanne Capital. The firm provided mezzanine financing to Kairos in June 2018, with the aim of financing the company's expansion strategy in a cost-effective way that would not dilute its equity.

The GP provided capital for Kairos via its Pride Mezzanine Capital I vehicle. The GP focuses on software and IT companies in the Benelux and DACH region with revenues of at least €3m and more than 20 employees, providing loans of at least €2m.

Company
Headquartered in Bochum, Kairos is a biobanking and clinical trial management software platform. Its software is used by university hospitals and research centres. Kairos also has offices in Berlin and Boston. The company employs fewer than 50 staff, according to LinkedIn.

People
Pride Capital – Lars van ‘t Hoenderdaal (managing partner).
Kairos – Martin Zünkeler (founder, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• DACH
• Technology
• Healthcare
• Trade sale
• Germany